Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
35 results
D3.35 - The influence of birth month on allergen sensitization patterns: A comprehensive analysis of skin prick test results in a large patient cohort
D3.36 - Chronic type non-IgE-mediated gastrointestinal food allergies, Clinical features and unclassified subgroup in the recent cohort
D3.37 - Optimal Single and Combinatorial Diagnostic Approaches for Wheat Allergy in Chinese Children
D3.38 - Elucidating the Causes of Discordant Results Between Two Specific IgE Assays Using Component-Resolved Diagnostics and Depletion Testing
D3.39 - Allergic contact dermatitis to oxidized fragrance components: a case of sensitization to hydroperoxides of limonene
D3.40 - Evaluation of wheat allergy diagnostic methods in children and potential cross-reactivity to other cereal grains
D3.44 - Global Trends in Google Search Interest for Allergic Diseases, Diagnostics and Therapies Over Two Decades
D3.46 - Safety of the EAACI risk assessment in hypersensitivity reactions to chemotherapy
D3.47 - Changes in Poaceae and Betulaceae pollen seasons correlate with patient sensitization profiles: a single-centre study over 4 decades
D3.41 - Population-based IgE profiling of adolescents using a multiplex allergen array
D3.43 - Classification of seasonal allergic rhinitis patients by prospective patient-recorded symptoms: the @IT.2020 project
D3.45 - Oral Food Challenge in children diagnosed with fish allergy. Our clinical experience
D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study
D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study
D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study
D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial
D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort
D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download